Got $250? 3 High-Growth Stocks on Sale to Buy Now
I'm not a big fan of handing out participation awards, but the investing community certainly deserves one in 2020 because of the way it's navigated through this historic volatility. This year, we've watched the unprecedented coronavirus disease 2019 (COVID-19) shave more than a third off of the broad-based S&P 500 in less than five weeks. The benchmark index then recouped everything that was lost in under five months. That's the steepest bear-market decline of at least 30%, as well as the fastest rebound to new highs from a bear market bottom, in history.
However, wild vacillations in the stock market aren't necessarily a bad thing. Since high-quality companies tend to increase in value over time, short-term moves lower that are emotion-driven provide an opportunity for long-term investors to put their capital to work.
Over the past week, we've watched a number of high-growth names get taken to the woodshed on the prospect of a successful COVID-19 vaccine hitting pharmacy shelves in the coming months. That's opened the door for investors to strike.
Source Fool.com
